Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Johannesburg Stock Exchange  >  Aspen Pharmacare Holdings Limited    APNJ   ZAE000066692

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Johannesburg Stock Exchan…
01/17/2018 01/18/2018 01/19/2018 01/22/2018 01/23/2018 Date
258.67 256 256.5 254.5 258.46 Last
2076837 1380178 2814159 1263180 1107243 Volume
-0.14% -1.03% +0.20% -0.78% +1.56% Change
Financials ( ZAR)
Sales 2018 45 685 M
EBIT 2018 11 705 M
Net income 2018 6 780 M
Debt 2018 42 215 M
Yield 2018 1,34%
Sales 2019 48 933 M
EBIT 2019 13 057 M
Net income 2019 9 219 M
Debt 2019 40 087 M
Yield 2019 1,48%
P/E ratio 2018 15,90
P/E ratio 2019 12,81
EV / Sales2018 3,47x
EV / Sales2019 3,19x
Capitalization 116 B
More Financials
Company
Aspen Pharmacare Holdings Ltd. engages in the manufacture and supply of branded and generic pharmaceutical products.The firm operates through the following segments: Commercial Pharmaceuticals, Nutritionals, and Manufacturing.The Commercial Pharmaceuticals segment comprises of the Anaesthetic;... 
Sector
Pharmaceuticals
Calendar
03/08Earnings Release
More about the company
Surperformance© ratings of Aspen Pharmacare Holdings
Trading Rating : Investor Rating :
More Ratings
Latest news on ASPEN PHARMACARE HOLDINGS
01/17 ASPEN PHARMACARE : Drugmaker GSK cuts back in Africa to hone emerging markets mo..
01/16 ASPEN PHARMACARE : wants trades audited
01/11 ASPEN PHARMACARE : share price knocked by rumours of investigation target
01/11 ASPEN PHARMACARE : claims manipulation
01/11 ASPEN PHARMACARE : share price knocked by rumours of investigation target
2017 ASPEN PHARMACARE : Ngonyama to head audit committee
2017 ASPEN PHARMACARE : cover story/paradise papers. THE APPLE OF ASPEN'S EYE
2017 ASPEN PHARMACARE : found fit and healthy to finalise AstraZeneca deal
2017 ASPEN PHARMACARE : found fit and healthy to finalise AstraZeneca deal
2017 ASPEN PHARMACARE : completes acquisition of AstraZenecas anaesthetics portfolio
More news
Sector news : Generic Pharmaceuticals
08:48a Drug Firms Bet Billions on Biotech -- WSJ
01/22 WILLIAM ACKMAN : Ackman cuts staff, shuns limelight as he seeks to turn around f..
01/22 TSX dips as railroad and materials shares weigh
01/22 Stocks hit record as senators reach deal to end shutdown
01/22 Canada's small financial firms get buzz from weed stocks
More sector news : Generic Pharmaceuticals
Latest Tweets
01/19Jefferies Group Raises Aspen Pharmacare FY2018 Earnings Estimates to $1.43 EP.. 
01/19Jefferies Group Raises Aspen Pharmacare FY2022 Earnings Estimates to $2.14 EP.. 
01/12Regulator reviewing Aspen Pharmacare's volatile share trading
4
2017$APN - John Williamson Sells 500,000 Shares of Aspen Pharmacare Holdings Limi.. 
2017$APN - John Williamson Acquires 75,000 Shares of Aspen Pharmacare Holdings Li.. 
More tweets
Qtime:16
News from SeekingAlpha
2017 Aspen Pharmacare Holdings (APNHY) Investor Presentation - Slideshow
2017 Aspen Pharmacare Has Continued To Grow And Branch Out
2016 Wobbles Aside, Small Pharma Shares Broadly On The Up In 2015
2015 Sector's Smaller Players Show The Way
2015 OPPORTUNITIES AND RISKS IN THE BIOTE : 2 Companies In South Africa
Chart ASPEN PHARMACARE HOLDINGS
Duration : Period :
Aspen Pharmacare Holdings  Technical Analysis Chart | APNJ | ZAE000066692 | 4-Traders
Technical analysis trends ASPEN PHARMACARE HOLDINGS
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Average target price 326  ZAR
Spread / Average Target 28%
EPS Revisions
Managers
NameTitle
Stephen Bradley Saad Group Chief Executive Officer & Executive Director
Douglas Dlamini Chairman
Lorraine Hill Group Operating Officer
Sean Capazorio Group Finance Officer
Michael Guy Attridge Executive Director & Group Deputy CEO
Sector and Competitors